Dr. Purvi Gada

Director

 

Profile

Dr. Kimryn Rathmell

MD, Duke University School of Medicine
PhD in Biophysics, University of North Carolina at Chapel Hill
Residency in Internal Medicine, University of North Carolina Hospitals
Fellowship in Medical Oncology, University of North Carolina Lineberger Comprehensive Cancer Center

Current Role At Neovita

Dr. Kimryn Rathmell collaborates with NeoVita Oncology as a strategic advisor, bringing her global leadership as Director of the U.S. National Cancer Institute (NCI) to strengthen international partnerships, clinical innovation, and research translation across NeoVita’s global centers.

Expertise & Specialization

• Genitourinary cancers, with emphasis on kidney cancer
• Molecular biology and genomics of cancer
•National and international oncology policy and strategy

Memberships & Affiliation

• American Society of Hematology (ASH)
• American Society of Clinical Oncology (ASCO)
•National Cancer Advisory Board (former)
•Leadership roles in international oncology collaborations

Biography

Dr. Kimryn Rathmell earned her MD from Duke University School of Medicine and her PhD in Biophysics from the University of North Carolina at Chapel Hill. She trained in Internal Medicine and later completed a fellowship in Medical Oncology at the University of North Carolina Lineberger Comprehensive Cancer Center. Before her appointment as Director of the U.S. National Cancer Institute in 2023, Dr. Rathmell served as Chair of Medicine at Vanderbilt University Medical Center, where she was also the Cornelius Abernathy Craig Professor of Medicine. At NeoVita, she leverages her expertise to advance cancer genomics, clinical innovation, and international research cooperation.

 

 

Career highlights & Achievements 

Dr. Rathmell is a globally recognized leader in oncology, known for her groundbreaking research into the molecular underpinnings of kidney cancer. As Director of the National Cancer Institute (appointed in 2023), she oversees the United States’ largest federal cancer research organization, guiding both laboratory science and clinical application. Her research has identified genetic drivers of renal cell carcinoma, contributing to new treatment paradigms. She has received numerous awards for scientific excellence, mentored generations of oncologists, and advocates for equitable access to cancer care worldwide.

Contact Information

📍 Address: 221B Baker Street, London, U.K.

🕒 Opening Hours: Monday – Friday, 8:00 AM – 6:00 PM

✉️ Email: physicians@neovitaoncology.org

Websites & Profiles